Allergy Relief Tablet, Film Coated
NDC Package 49483-061-62
Package Information
Allergy Relief (diphenhydramine hydrochloride) tablets is uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny noseitchy, watery eyessneezingitchy nose or throattemporarily relieves these symptoms due to the common cold:runny nosesneezing. This formulation utilizes a tablet, film coated delivery system. Marketed by Time Cap Laboratories, Inc, this product is identified by NDC 49483-061 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1049630 - diphenhydrAMINE HCl 25 MG Oral Tablet
- RxCUI: 1049630 - diphenhydramine hydrochloride 25 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 49483 - Time Cap Laboratories, Inc
- 49483-061 - Allergy Relief
- 49483-061-62 - 650 TABLET, FILM COATED in 1 BOTTLE
- 49483-061 - Allergy Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (49483-061). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 49483-061-62 identifies a specific commercial package of 650 tablet, film coated in 1 bottle of Allergy Relief, a human over the counter drug labeled by Time Cap Laboratories, Inc. This tablet, film coated is formulated for oral use and contains diphenhydramine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Time Cap Laboratories, Inc on May 01, 2012. The current certification is valid through December 31, 2026.
How is this Time Cap Laboratories, Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 49483006162. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.